Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) episode artwork

EPISODE · Jun 6, 2024 · 57 MIN

Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

from Leukemia CancerCare Connect Education Workshops

- Review of Chronic Lymphocytic Leukemia - Significant Role of Testing in Informing Treatment Choices - First-Line Treatment Options - Treatment for Relapsed & Refractory CLL - Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments - Current Perspectives on New & Emerging Treatments of CLL - Updates on Clinical Trials & Their Significance for CLL - Key Questions to Ask & Re-Ask Your CLL Health Care Team - Practical & Psychosocial Support to Cope with CLL - Questions for Our Panel of Experts

Episode metadata supplied by the publisher feed · Published Jun 6, 2024

Embed this episode

Ready to play

Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

0:00 57:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Leukemia CancerCare Connect Education Workshops?

This episode is 57 minutes long.

When was this Leukemia CancerCare Connect Education Workshops episode published?

This episode was published on June 6, 2024.

Can I download this Leukemia CancerCare Connect Education Workshops episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!